Literature DB >> 21864584

Sporulation studies in Clostridium difficile.

David A Burns1, Nigel P Minton.   

Abstract

Clostridium difficile is a leading cause of healthcare-associated diarrhoea. In recent years, certain C. difficile types have become highly represented among clinical isolates and are associated with outbreaks of increased disease severity, higher relapse rates and an expanded repertoire of antibiotic resistance. Endospores, produced during sporulation, play a pivotal role in infection and disease transmission and it has been suggested in the literature that these so-called 'hypervirulent' C. difficile types are more prolific in terms of sporulation in vitro. However, work in our laboratory has provided evidence to the contrary suggesting that although there is significant strain-to-strain variation in C. difficile sporulation characteristics this variation does not appear to be type-associated. On analysis of the literature, it is apparent that the methods used to quantify sporulation in previous studies have varied greatly and sample sizes have remained small. The conflicting data in the literature may, therefore, not necessarily be generally representative of C. difficile sporulation. Instead, these inconsistencies may reflect differences in the experimental design of each study. In this review, the need for further investigations of C. difficile sporulation rates is highlighted. Specifically, the advantages and disadvantages of the different experimental approaches previously used are discussed and a standard set of principles for measuring C. difficile sporulation in the future is proposed.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21864584     DOI: 10.1016/j.mimet.2011.07.017

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  33 in total

1.  Evaluation of growth and sporulation of a non-toxigenic strain of Clostridioides difficile (Z31) and its shelf viability.

Authors:  Carlos Augusto Oliveira Júnior; Rodrigo Otávio Silveira Silva; Diogo Soares Gonçalves Cruz; Isadora Honorato Pires; Guilherme Guerra Alves; Francisco Carlos Faria Lobato
Journal:  Braz J Microbiol       Date:  2018-12-18       Impact factor: 2.476

2.  In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, against Clostridium difficile.

Authors:  Tarun Mathur; Tarani Kanta Barman; Manoj Kumar; Diksha Singh; Ram Kumar; Manoj Kumar Khera; Makiko Yamada; Shin-Ichi Inoue; Dilip Jatashankar Upadhyay; Nobuhisa Masuda
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

3.  SpoIVA and SipL are Clostridium difficile spore morphogenetic proteins.

Authors:  Emily E Putnam; Adam M Nock; Trevor D Lawley; Aimee Shen
Journal:  J Bacteriol       Date:  2013-01-04       Impact factor: 3.490

Review 4.  Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.

Authors:  Milena M Awad; Priscilla A Johanesen; Glen P Carter; Edward Rose; Dena Lyras
Journal:  Gut Microbes       Date:  2014

5.  Isolating and Purifying Clostridium difficile Spores.

Authors:  Adrianne N Edwards; Shonna M McBride
Journal:  Methods Mol Biol       Date:  2016

6.  Culturing and maintaining Clostridium difficile in an anaerobic environment.

Authors:  Adrianne N Edwards; Jose M Suárez; Shonna M McBride
Journal:  J Vis Exp       Date:  2013-09-14       Impact factor: 1.355

7.  A pilot observational study of hydrogen peroxide and alcohol for disinfection of privacy curtains contaminated by MRSA, VRE and Clostridium difficile.

Authors:  Geetika Sood; Kerri Huber; Lisa Dam; Jonathan Zenilman; Stefan Riedel
Journal:  J Infect Prev       Date:  2014-09

8.  In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections.

Authors:  Hans H Locher; Peter Seiler; Xinhua Chen; Susanne Schroeder; Philippe Pfaff; Michel Enderlin; Axel Klenk; Elvire Fournier; Christian Hubschwerlen; Daniel Ritz; Ciaran P Kelly; Wolfgang Keck
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

9.  Curcumin: A natural derivative with antibacterial activity against Clostridium difficile.

Authors:  Deepansh Mody; Ahmad I M Athamneh; Mohamed N Seleem
Journal:  J Glob Antimicrob Resist       Date:  2019-10-14       Impact factor: 4.035

10.  Characterization of a stable, metronidazole-resistant Clostridium difficile clinical isolate.

Authors:  Tarah Lynch; Patrick Chong; Jason Zhang; Romeo Hizon; Tim Du; Morag R Graham; Daniel R Beniac; Timothy F Booth; Pamela Kibsey; Mark Miller; Denise Gravel; Michael R Mulvey
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.